Article date: July 1994
By: Adele Lucchelli, Maria Grazia Santagostino‐Barbone, Annalisa Barbieri, Marcello Tonini, in Volume 112, Issue 3, pages 763-768
Experiments were carried out to characterize the receptors mediating the indirect excitatory response to 5‐hydroxytryptamine (5‐HT) in the guinea‐pig isolated trachea.
5‐HT caused concentration‐dependent contractions of tracheal strips, and the resulting concentration‐response curve was biphasic in nature. The first phase was obtained with agonist concentrations in the range of 0.01–3 nm and achieved a maximum which was 30% of the total 5‐HT response, while the second phase was in the range 10 nm–1 μm.
Atropine (0.1 μm) and tetrodotoxin (TTX: 0.3 μm) significantly reduced both phases of the 5‐HT curve. Morphine (10 μm), which can act to inhibit neuronal acetylcholine release, abolished the first phase and reduced the second phase. This suggests that the first phase is mainly neurogenic (cholinergic) in nature, while the second phase is in part neurogenic and in part due to direct activation of the effector cells.
The 5‐HT2A receptor antagonist, ketanserin (0.01, 0.1 μm) markedly depressed the first phase and shifted the second phase to the right in a parallel manner, with some depression of the 5‐HT response maximum. The less selective (5‐HT1/5‐HT2A) antagonist, methiothepin (0.1 μm) mimicked the action of ketanserin, albeit with less potency. Concomitant administration of ketanserin and methiothepin (each at 0.1 μm) produced an antagonism similar to that caused by ketanserin (0.1 μm) alone.
The 5‐HT3 receptor antagonists, ondansetron (0.1 μm) and granisetron (0.01 μm) slightly but significantly inhibited the first phase of the 5‐HT curve without altering the second phase. SDZ 205,557 (0.3 μm), a 5‐HT4 receptor antagonist, was ineffective.
Our results suggest that neural 5‐HT2A and, to a lesser extent, 5‐HT3 receptor subtypes mediate the first phase of the 5‐HT curve in the guinea‐pig trachea. The second phase is mediated by 5‐HT2A receptors, which are probably located at both the neural and muscular level. No evidence for the participation of 5‐HT1 receptors in the 5‐HT response has been obtained.
Experiments were carried out to characterize the receptors mediating the indirect excitatory response to 5‐hydroxytryptamine (5‐HT) in the guinea‐pig isolated trachea.
5‐HT caused concentration‐dependent contractions of tracheal strips, and the resulting concentration‐response curve was biphasic in nature. The first phase was obtained with agonist concentrations in the range of 0.01–3 nm and achieved a maximum which was 30% of the total 5‐HT response, while the second phase was in the range 10 nm–1 μm.
Atropine (0.1 μm) and tetrodotoxin (TTX: 0.3 μm) significantly reduced both phases of the 5‐HT curve. Morphine (10 μm), which can act to inhibit neuronal acetylcholine release, abolished the first phase and reduced the second phase. This suggests that the first phase is mainly neurogenic (cholinergic) in nature, while the second phase is in part neurogenic and in part due to direct activation of the effector cells.
The 5‐HT2A receptor antagonist, ketanserin (0.01, 0.1 μm) markedly depressed the first phase and shifted the second phase to the right in a parallel manner, with some depression of the 5‐HT response maximum. The less selective (5‐HT1/5‐HT2A) antagonist, methiothepin (0.1 μm) mimicked the action of ketanserin, albeit with less potency. Concomitant administration of ketanserin and methiothepin (each at 0.1 μm) produced an antagonism similar to that caused by ketanserin (0.1 μm) alone.
The 5‐HT3 receptor antagonists, ondansetron (0.1 μm) and granisetron (0.01 μm) slightly but significantly inhibited the first phase of the 5‐HT curve without altering the second phase. SDZ 205,557 (0.3 μm), a 5‐HT4 receptor antagonist, was ineffective.
Our results suggest that neural 5‐HT2A and, to a lesser extent, 5‐HT3 receptor subtypes mediate the first phase of the 5‐HT curve in the guinea‐pig trachea. The second phase is mediated by 5‐HT2A receptors, which are probably located at both the neural and muscular level. No evidence for the participation of 5‐HT1 receptors in the 5‐HT response has been obtained.
DOI: 10.1111/j.1476-5381.1994.tb13144.x
View this article